Document is current
Any future updates will be listed below
-
Authors
Abbott, Jane
Aldhouse, Natalie V. J.
Kitchen, Helen
Pegram, Hannah C.
Brown, Fiona
Macartney, Malcolm
Villasis-Keever, Angelina
Sbarigia, Urbano
Ito, Tetsuro
Chan, Eric K. H.
Kennedy, Patrick T. http://orcid.org/0000-0001-9201-0094
-
Funding
Funding for this research was provided by:
Janssen Pharmaceuticals (Janssen Pharmaceuticals)
- License Information
-
More Information
Article History
Received: 14 June 2023
Accepted: 12 December 2023
First Online: 4 March 2024
Declarations
:
: This study was reviewed by the local ethics committee/institutional review board and was performed in accordance with the ethical principles of the Declaration of Helsinki.
: All study participants provided written informed consent.
: Individual participant data, including quotes from participants, have been anonymized, and the authors affirm that participants provided consent to having their data published.
: JA has no disclosures in relation to this study. NVJA and HK are employees and stockholders of Clarivate, a health economics and outcomes research consultancy that consults for various pharmaceutical companies, including Janssen Global Services, LLC, which funded the conduct of this study. HCP and FB were employees of Clarivate at the time this study was conducted, and HCP holds stock in Clarivate. MM, AV-K, US, TI, and EKHC are employees of Janssen Pharmaceuticals and Johnson & Johnson stockholders. PTK has received payment for participation in speakers bureaus and consultancy for Janssen, Gilead Sciences, Aligos, MedImmune, and GlaxoSmithKline, and has received grant support from Gilead Sciences.
